Cyclic AMP Potentiation of Interferon Antiviral Activity and Effect of Interferon on Cellular Cyclic AMP Levels

References

1. Allen L. B., Eagle N. C., Huffman J. H., Shuman D. A., Meyer R. B., Sidwell R. W. 1974; Enhancement of interferon antiviral action in L-cells by cyclic nucleotides. Proceedings of the Society for Experimental Biology and Medicine 146:580–584
   [Google Scholar]
2. Atkinson D. E. 1968; The energy charge of the adenylate pool as a regulatory parameter. Interaction with feedback modifiers. Biochemistry 7:4030–4034
   [Google Scholar]
3. Bannai S., Sheppard J. R. 1974; Cyclic AMP, ATP and cell contact. Nature, London 250:62–64
   [Google Scholar]
4. Biron K. K., Raska K. 1973; Effects of dibutyryl-cAMP on adenovirus replication in different cell lines. Virology 56:383–385
   [Google Scholar]
5. Braun W., Levy H. B. 1972; Interferon preparations as modifiers of immune responses. Proceedings of the Society for Experimental Biology and Medicine 141:769–773
   [Google Scholar]
6. Burger M. M., Bombik B. M., Breckenridge B. M., Sheppard J. R. F. 1972; Growth control and cyclic alterations of cyclic AMP in the cell cycle. Nature New Biology 239:161–163
   [Google Scholar]
7. Butcher R. W., Sutherland E. W. 1962; Adenosine 3′, 5′-phosphate in biological materials. I. Purification and properties of cyclic 3′, 5′-nucleotide phosphodiesterase and use of this enzyme to characterize adenosine 3′, 5′-phosphate in human urine. Journal of Biological Chemistry 237:1244–1250
   [Google Scholar]
8. Friedman R. M., Pastan I. 1969; Monophosphate: potentiation of antiviral activity. Biochemical and Biophysical Research Communications 36:735–740
   [Google Scholar]
9. Gilman A. G. 1970; A protein binding assay for adenosine 3′, 5′-cyclic monophosphate. Proceedings of the National Academy of Sciences of the United States of America 67:305–312
   [Google Scholar]
10. Gilman A. G. 1972; Protein binding assays for cyclic nucleotides. In Advances in Cyclic Nucleotide Research vol 2 pp 9–24 Edited by Greengard P., Robison G. A. New York: Raven Press;
    [Google Scholar]
11. Goldberg N. D., O’Dea R. F., Haddox M. K. 1973; Cyclic GMP. In Advances in Cyclic Nucleotide Research vol 3 pp 155–223 Edited by Greengard P., Robison G. A. New York: Raven Press;
    [Google Scholar]
12. Gresser I. 1972; Antitumour effects of interferon. Advances in Cancer Research 16:97–140
    [Google Scholar]
13. Gresser I., Bandu M.-T., Tovey M., Bodo G., Paucker K., Stewart W. 1973; Interferon and cell division. VII. Inhibitory effect of highly purified interferon preparations on the multiplication of leukemia L1210 cells. Proceedings of the Society for Experimental Biology and Medicine 142:7–10
    [Google Scholar]
14. Krishna G., Weiss B., Brodie B. B. 1968; A simple sensitive method for the assay of adenyl cyclase. Journal of Pharmacology and Experimental Therapeutics 163:379–385
    [Google Scholar]
15. Kurth R., Bauer H. 1973; Influence of dibutyryl cyclic AMP and theophylline on cell surface antigens on oncornavirus transformed cells. Nature New Biology 243:243–245
    [Google Scholar]
16. Lee S. H. S., O’shaughnessy M. V., Rozee K. R. 1972; Interferon induced growth depression in diploid and heterodiploid human cells. Proceedings of the Society for Experimental Biology and Medicine 139:1438–1440
    [Google Scholar]
17. Lockart R. Z. 1973; Criteria for acceptance of a viral inhibitor as interferon and a general description of the biological properties of known interferons. In Interferons and Interferon Inducers Frontiers of Biology vol 2 pp 11–27 Edited by Finter N. B. Amsterdam: North-Holland Publishing Co;
    [Google Scholar]
18. Lowry O. H., Rosebrough N. J., Farr A. L., Randall R. J. 1951; Protein measurement with the Folin phenol reagent. Journal of Biological Chemistry 193:265–275
    [Google Scholar]
19. Millis A. J. T., Forrest G., Pious D. A. 1972; Cyclic AMP in cultured human lymphoid cells: relationship to mitosis. Biochemical and Biophysical Research Communications 49:1645–1649
    [Google Scholar]
20. Otten J., Johnson G. S., Pastan I. 1972; Regulation of cell growth by cyclic adenosine 3′, 5′-mono-phosphate. Journal of Biological Chemistry 247:7082–7087
    [Google Scholar]
21. Paucker K., Berman B. J., Golgher R. R., Stancek D. 1970; Purification, characterization, and attempts at isotopic labelling of mouse interferon. Journal of Virology 5:145–152
    [Google Scholar]
22. Perkins J. P. 1973; Adenyl cyclase. In Advances in Cyclic Nucleotide Research vol 3 pp 1–64 Edited by Greengard P., Robison G. A. New York: Raven Press;
    [Google Scholar]
23. Posternak T., Sutherland E. W., Henion W. F. 1962; Derivatives of cyclic 3′, 5′-adenosine monophosphate. Biochimica et Biophysica Acta 65:558–560
    [Google Scholar]
24. Rozengurt E., De Asua L. J. 1973; Role of cyclic 3′, 5′-adenosine monophosphate in the early transport changes induced by serum and insulin in quiescent fibroblasts. Proceedings of the National Academy of Sciences of the United States of America 70:3609–3612
    [Google Scholar]
25. Schroder J., Placeman P. G. 1971; Growth of Novikoff rat hepatoma cells in suspension culture in the presence of adenosine 3′, 5′-cyclic monophosphate. Journal of the National Cancer Institute 46:423–429
    [Google Scholar]
26. Sheppard J. R. 1972; Difference in the cyclic adenosine 3′, 5′-monophosphate levels in normal and transformed cells. Nature New Biology 236:14–16
    [Google Scholar]
27. Webb D., Braun W., Plescia O. J. 1972; Antitumor effects of polynucleotides and theophylline. Cancer Research 32:1814–1819
    [Google Scholar]
28. Weber J. M., Stewart R. B. 1973; Interaction of interferon with cells: limited heterologous reactivity of chick and mouse interferons. Journal of General Virology 19:165–174
    [Google Scholar]
29. Weiss B., Schlesinger S. 1973; Defective interfering passages of Sindbis virus: chemical composition, biological activity and mode of interference. Journal of Virology 12862–871
    [Google Scholar]